← All tickers

Is NVAX Worth Buying in 2026?

Novavax Inc

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-05-24

Here’s whether Novavax Inc (NVAX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 62 — healthy momentum range; strong 1-year return of +26.3%. Concerns: 50-day MA is falling (-2.20% over 10 days). Currently 23.1% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

NVAX is in a confirmed uptrend, trading above both its 50-day ($8.81) and 200-day ($8.35) moving averages. An RSI of 62.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +26.3% compares to +27.9% for SPY (trailed the market by 1.5%). The current 23.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $12,634 today
vs. S&P 500 (SPY) — same period trailed market by 1.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($8.35)
✓Above 50-day MA ($8.81)
✓RSI(14) neutral zone (30–70) — currently 62.0
✓Positive return (+26.3%)
!Within 10% of period high (−23.1%)
Period Range $9.21
$6.13 $11.97
RSI (14) 62.0
0 · OversoldOverbought · 100

Key Metrics

Price$9.21
Period Return+26.3%
Period High$11.97
Period Low$6.13
Drawdown−23.1%
MA-50$8.81
MA-200$8.35
RSI (14)62.0
Avg Volume (30d)4.7M
vs. SPYtrailed by 1.5%
Return Rank#508 of 1236

Trade NVAX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers